Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 1193397 crossover study in type 2 diabetes
2015-003799-63Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of BAY1193397 in diabetic peripheral angiopathy (DPA) and diabetic foot ulcer (DFU) (3 arms), sponsored by Bayer. Started Feb 2017; status: completed.
02
Drugs
BAY1193397
03
Conditions
diabetic peripheral angiopathy (DPA)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2015-003799-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003799-63.